ClinicalTrials.govpublic full text
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
type 2 diabetes mellitus, diabetes mellitus, diabetes mellitus, type 2, glucose metabolism disorders, metabolic diseases, endocrine system diseases, hypoglycemic agents, physiological effects of drugs, tirzepatide, incretins, glucagon-like peptide 1, gastric inhibitory polypeptide
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 894538
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.